Matrixx Resumes Increased R&D To Generate New Products
This article was originally published in The Tan Sheet
Executive Summary
Zicam marketer Matrixx plans to increase research spending in order to renew its focus on new product development as a strategy to drive growth
You may also be interested in...
Matrixx Plans Extensive Zicam Marketing For Upcoming Cold Season
Matrixx Initiatives will promote its Zicam and Nasal Comfort cough, cold and allergy products with an original multimedia marketing campaign in the second half of 2005
NACDS Marketplace In Brief
Bayer Rapid Headache Relief: TV spot supporting the launch of Bayer Rapid Headache Relief claims the product "releases medicine" five times faster than Tylenol Gels. The spot broke on national network and cable channels May 31. The product, which contains 500 mg aspirin/65 mg caffeine, was featured by Bayer at the National Association of Chain Drug Stores Marketplace in New Orleans June 5-7. A 50-count package retails for $5.25. The TV spot opens with a mother driving her children to soccer practice as an announcer says, "The number one cause of headaches: everyday life. Want fast relief? Introducing new Bayer Rapid Headache Relief." A message superimposed over an image of the Bayer and Tylenol Gel capsules dissolving notes the elapsed release time is 27 seconds for Bayer's product and 133 seconds for Tylenol...
Zinc Gluconate Sprays Challenged In Lawsuits; Matrixx Defends Zicam Safety
The safety of zinc gluconate sprays has been called into question by a recent spate of lawsuits alleging that the products cause users to lose their sense of smell